Coronary Drug Project Mortality Surveillance

An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)

NCT00644332 ·Status: COMPLETED ·Phase: PHASE4

NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy

NCT00293137 ·Status: TERMINATED

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

NCT00655538 ·Status: COMPLETED ·Phase: PHASE2

Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI

NCT07138508 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of LY2216684 and Digoxin in Healthy Subjects

NCT01266590 ·Status: COMPLETED ·Phase: PHASE1

Prevention and Pharmacological Management of Cardiac Adverse Drug Reactions Induced by Drugs Used in Oncology.

NCT03678337 ·Status: UNKNOWN

Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction

NCT05350969 ·Status: COMPLETED ·Phase: PHASE2

Therapeutic Drug Monitoring of Cardiac Medications

NCT03667781 ·Status: TERMINATED

Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure

NCT01252810 ·Status: COMPLETED ·Phase: PHASE2

Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands

NCT03783429 ·Status: COMPLETED ·Phase: PHASE4

Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)

NCT01481402 ·Status: COMPLETED ·Phase: NA

Desflurane-induced Myocardial Protection

NCT02019797 ·Status: UNKNOWN ·Phase: PHASE4

Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia

NCT01161121 ·Status: COMPLETED ·Phase: PHASE1

Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes

NCT01704638 ·Status: COMPLETED ·Phase: PHASE1

Amiodarone Compared to Dronedarone , Post Cardioversion Maintenance of Sinus Rhythm

NCT01266681 ·Status: UNKNOWN ·Phase: NA

Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction

NCT04308031 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure

NCT01092325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation

NCT05469308 ·Status: UNKNOWN ·Phase: NA

Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina

NCT01396395 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Study to Assess the Effect of Enlicitide on How the Body Processes Digoxin in Healthy Adult Participants (MK-0616-031)

NCT06597760 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin

NCT07118215 ·Status: RECRUITING ·Phase: PHASE1

An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia

NCT05117346 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil

NCT01475123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging

NCT01021618 ·Status: COMPLETED ·Phase: NA

Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461

NCT02329184 ·Status: COMPLETED ·Phase: PHASE1